A. No. Based on available evidence, FDA has concluded that THC and CBD products are excluded from the dietary supplement definition under sections 201(ff)(3)(B)(i) and (ii) of the FD&C Act, respectively. Under those provisions, if a substance (such as THC or CBD) is an active ingredient in a drug product that has been approved under 21 U.S.C. § 355 (section 505 of the FD&C Act), or has been authorized for investigation as a new drug for which substantial clinical investigations have been instituted and for which the existence of such investigations has been made public, then products containing that substance are outside the definition of a dietary supplement. FDA considers a substance to be "authorized for investigation as a new drug" if it is the subject of an Investigational New Drug application (IND) that has gone into effect. Under FDA’s regulations (21 CFR 312.2), unless a clinical investigation meets the limited criteria in that regulation, an IND is required for all clinical investigations of products that are subject to section 505 of the FD&C Act.
Es recomendable que las vías de administración en estas patologías sean tanto de acción local como general. Esto se traduce en el uso de cremas o lociones a ser aplicados en los puntos dolorosos, sumados a la ingestión de aceites o tinturas. De este modo, al tiempo que se tratan los síntomas dolorosos e inflamatorios de la enfermedad reumática por vía general y se busca incidir en una modulación de auto-inmunidad, se puede ser más eficaz en el alivio del dolor sin tener que apelar a altas dosis de THC. Las cremas con THC usadas localmente en principio no generan efectos psicoactivos, aunque se debe estar alerta a posibles reacciones alérgicas al THC.
Cannabis Lotion: With marijuana’s proven reputation for pain relief, it’s no wonder that topicals (products placed on the skin) have become such big business for cannabis retailers. From lotions to balms to massage oils, cannabis products have been selling faster than some companies can produce them. According to Amanda Reiman of Drug Policy, topical cannabis products “can be extremely helpful for localized pain and inflammation.” Of course, smoking, vaping, or dabbing is also helpful for pain and inflammation – but not nearly as discreet. Topical cannabis products also begin working as soon as they are applied in most cases, and do not contain much THC, making them non-psychoactive. Without a high level of THC, these products are highly unlikely to cause a failed drug test, as long as you don’t indulge in other, traceable ways such as smoking, edibles, or dabbing.